peptides
Best SellerIpamorelin
Ipamorelin is a selective growth hormone secretagogue pentapeptide studied for its high GHS-R1a receptor selectivity in in vitro research models.
In vitro research use only Β· Not for human or animal use
π $10 Flat-Rate Shipping Β· Free Local Pickup

5mg/5mg
Select Size
A pre-combined research vial containing CJC-1295 (No DAC) and Ipamorelin for studies examining GHRH receptor and GHS-R1a receptor co-activation in in vitro models.
Notify me when back in stock
Ships from Florida Β· Typically dispatches in 1β2 business days
A pre-combined research vial containing CJC-1295 (No DAC) and Ipamorelin for studies examining GHRH receptor and GHS-R1a receptor co-activation in in vitro models.
This blend pairs CJC-1295 (No DAC), a GHRH analogue, with Ipamorelin, a selective GHS-R1a agonist. The combination is used in research examining the downstream effects of simultaneous GHRH receptor and growth hormone secretagogue receptor activation in cell-based assays. For qualified laboratory research only.
CJC-1295 (No DAC) + Ipamorelin (5mg/5mg) is supplied by Coastal Bio Labs as a research-grade compound for in vitro laboratory research use only. Not for human or animal use, diagnosis, or treatment.
Follow the current lot documentation and a validated laboratory protocol for storage, solvent compatibility, concentration, and stability.
Handle per applicable laboratory safety protocols. This compound is for in vitro research only.
Purity: No public batch result currently linked
Batch document: Available documentation may be requested by lot
Interpretation: Review the methods and limitations stated on the actual report
$10.00 flat-rate standard shipping, or free local pickup. Shipped orders are dispatched within 1β2 business days in plain, discreet packaging.
All sales are final once shipped. See our Refund Policy for full details.
A pre-combined research vial containing CJC-1295 (No DAC) and Ipamorelin for studies examining GHRH receptor and GHS-R1a receptor co-activation in in vitro models.
This blend pairs CJC-1295 (No DAC), a GHRH analogue, with Ipamorelin, a selective GHS-R1a agonist. The combination is used in research examining the downstream effects of simultaneous GHRH receptor and growth hormone secretagogue receptor activation in cell-based assays. For qualified laboratory research only.
No public batch result is currently linked for CJC-1295 (No DAC) + Ipamorelin (5mg/5mg). Request documentation for the relevant lot before relying on a purity or identity specification.
Follow the current lot documentation and a validated laboratory protocol for storage, solvent compatibility, concentration, and stability.
CJC-1295 (No DAC) + Ipamorelin (5mg/5mg) is sold by Coastal Bio Labs strictly as a research-grade compound for in vitro laboratory research use only. It is not a drug, supplement, or medical product and is not approved for human or animal use, diagnosis, or treatment. Researchers are responsible for compliance with all applicable institutional, state, and federal regulations.
peptides
Best SellerIpamorelin is a selective growth hormone secretagogue pentapeptide studied for its high GHS-R1a receptor selectivity in in vitro research models.
In vitro research use only Β· Not for human or animal use
peptides
CJC-1295 without DAC (Drug Affinity Complex) is a modified GHRH analogue with a shorter half-life profile, studied in GH axis receptor binding research.
In vitro research use only Β· Not for human or animal use
peptides
Sermorelin is a synthetic analogue of the first 29 amino acids of endogenous GHRH, studied in growth hormone axis research. Supplied as a lyophilized research compound.
In vitro research use only Β· Not for human or animal use